Overview
PROK market data
Price History
PROK price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.52 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.84 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -8,131.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.45 – $3.48 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $510.5M · P/S 574.22.
Company News
ProKidney Q2 EPS $(0.15) Misses $(0.14) Estimate, Sales $150.000K Beat $149.000K EstimateBenzinga · Aug 10, 2026, 8:25 PM
8-K filing — PROKIDNEY CORP. (PROK)SEC EDGAR · Aug 10, 2026, 8:11 PM
AEVEX, Abivax, Watts Water Technologies And Other Big Stocks Moving Higher On TuesdayBenzinga · Jun 30, 2026, 2:05 PM
Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market SessionBenzinga · Jun 29, 2026, 12:15 PM
HC Wainwright & Co. Reiterates Buy on ProKidney, Maintains $12 Price TargetBenzinga · May 18, 2026, 3:05 PM
ProKidney Q1 EPS $(0.14), Inline, Sales $226.000K Beat $143.667K EstimateBenzinga · May 15, 2026, 3:46 PM